Monsanto CEO: U.S. Regulatory System Is ‘Functional’

The following is an edited excerpt.

The head of the world’s largest seed company brushed aside suggestions the U.S. regulatory system has become too burdensome less than a week after a new Monsanto product was delayed by the Department of Agriculture.

Monsanto Chief Executive Hugh Grant is “not overly concerned” by the USDA’s decision last week to compile a fuller environmental assessment of the company’s latest soybean and cotton seeds—which are genetically modified to withstand the herbicide dicamba.

“There’s a lot of noise that the system is broken,” Mr. Grant said at the company’s headquarters on Tuesday. “The reality is the U.S. has over the past decade and a half had a functional system.”

Read the original article in its entirety here: Monsanto CEO: U.S. Regulatory System Is ‘Functional’

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-13-at-3.54.04-PM
AI disinformation stress test: Challenges and response strategies
ChatGPT-Image-Feb-16-2026-01_04_32-PM
Raw milk myth wake-up call
ChatGPT-Image-Apr-20-2026-11_17_18-AM-2
10,000 scientists gone: Trump’s cuts create an unprecedented brain drain
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
ChatGPT-Image-Apr-23-2026-09_20_20-PM
Kennedy’s CDC blocks publication of study that shows vaccines reduce hospitalizations by 50%, then misrepresents why

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.